Key statistics
On Tuesday, Foghorn Therapeutics Inc (FHTX:NMQ) closed at 5.45, -21.58% below its 52-week high of 6.95, set on Jan 13, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 5.44 |
|---|---|
| High | 5.64 |
| Low | 5.37 |
| Bid | 5.26 |
| Offer | 6.14 |
| Previous close | 5.45 |
| Average volume | 160.69k |
|---|---|
| Shares outstanding | 58.57m |
| Free float | 48.01m |
| P/E (TTM) | -- |
| Market cap | 319.22m USD |
| EPS (TTM) | -1.15 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
More ▼
- Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit
- Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
- Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
- Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
- Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update
- Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
- Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
- Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit
- Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
- Foghorn Therapeutics Provides Second Quarter 2025 Financial and Corporate Update
More ▼
